HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican Population of locally advanced breast cancer patients

By Muñoz-Gonzalez David   Zeichner-Gancz Isabel   Candelaria Myrna   Ramirez-Ugalde Maria   Perez-Sanchez Manuel   Cervantes-Vazquez Guadalupe   Cantu-de Leon David   Mora-Tizcareño Arcelia   Leonor-Ortíz Julio  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 23-28

Humana Press, Inc

Access to resources Recommend Favorite

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

By Bertucci François  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy

By Wang Jiayu  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 531-537

Springer Publishing Company

Access to resources Recommend Favorite

ERBB2 overexpression in breast carcinomas - no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

By Vincent-Salomon A.   Carton M.   Freneaux P.   Palangie T.   Beuzeboc P.   Mouret E.   de Cremoux P.   Coue O.   Zafrani B.   Nicolas A.   Clough K.   Fourquet A.   Pouillart P.   Sastre-Garau X.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 586-591

Elsevier

Access to resources Recommend Favorite

DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients

By Kawate Takahiko  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 51-59

Springer Publishing Company

Access to resources Recommend Favorite